FAIR Labels Act of 2026

Summary of H.R. 8596 – FAIR Labels Act of 2026

Jurisdiction: United States Congress, 119th Congress, 2nd Session

Purpose
- The FAIR Labels Act of 2026 aims to ensure consumers can make informed choices between traditional meat and poultry products and emerging cell-cultivated protein products, as well as plant-based alternative proteins.
- It establishes labeling and regulatory coordination to clarify product identity and origin across multiple federal agencies.

Key Provisions

1) Regulatory Coordination (Section 2)
- Revisions to a 2019 Memorandum of Understanding between the USDA and FDA.
- Within 90 days of enactment, USDA and HHS must jointly revise the agreement to:
- Define roles for regulating cell-cultivated protein products.
- Assign responsibilities to FDA and USDA for oversight of production materials, cell banks, culture processes, and inputs.
- Ensure compliance with applicable FDA authorities (facility registration, current good manufacturing practices, preventive controls, etc.).
- Establish inspections and enforcement to ensure cell-banks and culture facilities comply with laws.

2) Regulation and Labeling of Cell-Cultivated Protein Products (Section 3)
- Meat Inspection Act (and Poultry Products Inspection Act) amendments to explicitly cover cell-cultivated products.
- Definition of “cell-cultivated protein product”:
- A product for human consumption made wholly or in part from cell culture or DNA from an amenable animal species using animal cell culture technology.
- Grown or cultivated outside of the live animal source.
- Misbranding requirements:
- Labels must prominently and clearly indicate “cell-cultivated” next to the product name.
- Include a statement that the product is derived from sources other than meat or poultry, as applicable.
- Include a disclaimer that the product is not derived from, or does not contain, naturally produced meat or poultry from a live animal/bird.
- Applicability:
- Cell-cultivated products must be regulated under the same requirements as traditional meat or poultry products.

3) Regulation of Plant-Based Alternative Protein Products ( Section 3c)
- Definitions:
- Plant-based alternative protein product: a product made from plant species that mimics meat/powltry in texture, flavor, and appearance and is manufactured to resemble meat/poultry.
- Misbranding Requirements:
- Labels must identify the product as a “plant-based alternative protein product.”
- Include a prominent statement that the product is not derived from or does not contain naturally produced meat or poultry from a live animal or bird.
- Applicability:
- Plant-based products are subject to labeling standards similar to other food labeling rules under FDA authorities.

4) Standards of Identity (Section 3d)
- By 180 days after enactment, USDA (in consultation with HHS) must develop common standards of identity for:
- Cell-cultivated protein products.
- Plant-based alternative protein products.
- Standards aligned with the definitions in the Federal Meat Inspection Act, Poultry Products Inspection Act, and the FDA’s Federal Food, Drug, and Cosmetic Act.

5) Definitions and Labeling Terms (Section 3)
- Adds explicit definitions for cell-cultivated protein products under the meat and poultry inspection frameworks.
- Adds labeling terms to ensure visibility and consistency across product categories.

Affected Parties and Impacts

• Industry:

  • Meat and poultry processors may need to adjust labeling, packaging, and branding to meet new “cell-cultivated” labeling requirements.
  • Manufacturers of plant-based and cell-cultivated proteins will be subject to new labeling standards and identity/standard-of-identity rules.

• Federal Regulators:

  • FDA and USDA will share and clarify oversight responsibilities for cell-cultivated products, including facilities, cell banks, and manufacturing processes.
  • Requires updated interagency agreements and ongoing enforcement.

• Consumers:

  • Enhanced labeling aims to reduce confusion between traditional animal-derived products and cell-cultivated or plant-based alternatives.
  • Improves informed decision-making at the point of purchase.

Timeline and Procedural Notes

• The MOU revision must occur within 90 days after enactment.
• Standards of identity for relevant products to be developed within 180 days after enactment.
• The bill was introduced April 30, 2026, and referred to the House Committee on Agriculture and the Committee on Energy and Commerce.

Sponsors
- Primary sponsor: Representative Mark Alford (along with several co-sponsors: Tony Wieder, August Pfluger, Ronny Jackson, Mike Flood, Jason Smith, Buddy Carter, Mike Simpson, and more).

Overall Assessment
- The FAIR Labels Act of 2026 seeks to create clear, consistent, and prominently displayed labeling for cell-cultivated and plant-based protein products, and to harmonize regulatory oversight between USDA, FDA, and HHS. It emphasizes consumer clarity about whether a product is traditional meat/poultry, cell-cultivated, or plant-based, and sets timelines for performance standards and interagency coordination.